HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

483.015

-13.743-2.77%

Number of Gainers:8

Number of Losers:23

Number of Flat:2

PE:- -

High:496.758

Open:496.758

Low:480.328

Close:496.758

Volume:110.75M

Turnover:2.50B

Market Cap:306.93B

Float Cap:273.30B

Loading ...

China's Ocumension Therapeutics H1 Revenue Surges on Higher Ophthalmic Product Sales

Ocumension Therapeutics Shifts Hk$102.5 Million IPO Proceeds to Working Capital, General Corporate Uses

Ocumension Therapeutics FY26 H1 Net Loss Narrows 25.2% to RMB 99.02 Million; Revenue Rises 44.1% to RMB 423.7 Million

Ocumension Therapeutics - Board Does not Recommend Distribution of an Interim Dividend

THOMSON REUTERS

Ocumension Therapeutics - Adjusted Net Loss Narrowed by 46.7% to Rmb57.5 Mln for Six Months

THOMSON REUTERS

Alphamab Oncology - Board Resolves to Repurchase Shares up to HK$80 Mln in Value

THOMSON REUTERS

Alphamab Oncology Launches On-Market Share Buyback of up to HK$ 80 Million

EDDING GENOR Reports Interim Loss, Swinging to Deficit in First Half

China's Zhaoke Ophthalmology H1 Revenue Rises

Suzhou Basecare FY26 H1 Net Loss Narrows 40.7% to RMB 72.05 Million; Revenue Rises 27% to RMB 128.75 Million

Zhaoke Ophthalmology FY26 H1 Loss Widens to RMB 122.59 Million; Revenue Rises 19.14% to RMB 18.83 Million

Mabpharm FY26 H1 Profit More than Doubled to RMB 31.36 Million; Revenue Rises 45.1% to RMB 397.94 Million

Edding Genor Swings to FY26 H1 Net Loss of RMB 65.88 Million; Revenue Falls 23.1% to RMB 872.73 Million

Domestic Innovative Drug Sector Shifts From Cash Burn to Profit Generation as Mid-Year Reports Roll In

ZyLoxTB Allocates HK$1.16M to Buy Back 53,000 Shares on August 28

CStone Pharmaceuticals (SEHK:2616) Stock Price Reflects Growth While Losses Stay Heavy

Simply Wall St.

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return Reporting Share Repurchase at HKD 21.78-22.2

Alphamab Oncology (SEHK:9966) Stock Rally Meets Revenue Dip And Losses

Simply Wall St.

Goldman Sachs Lifts Innocare Price Target to HK$22.71 on Robust Orelabrutinib Sales

AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK1574/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":483.01477,"timestamp":1789114042807,"preClose":496.75812,"halted":0,"volume":110754813,"delay":0,"changeRate":-0.027666,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closing Auction","change":-13.743347,"latestTime":"09-11 16:00:00","open":496.75812,"high":496.75812,"low":480.32812,"amount":2498550761,"amplitude":0.033074,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":3.703217,"peRate":164.740195,"turnoverRate":0.004215,"increases":6,"decrements":25,"flats":1,"marketCap":306930068880,"floatMarketCap":273297591592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":496.75812,"amplitude":0.033074,"preClose":496.75812,"low":480.32812,"pbRate":"3.703217","latestPrice":483.01477,"volume":110754813,"delay":0,"open":496.75812,"prevYearClose":556.26263,"prevWeekClose":532.025,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":532.025,"twentyDayClose":518.327,"sixtyDayClose":434.471,"secType":"PLATE","market":"HK","turnoverRate":0.004215,"peRate":164.740195,"marketCap":306930068880,"floatMarketCap":273297591592,"timestamp":1789114042807,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":8,"down":23,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662099200","title":"China's Ocumension Therapeutics H1 Revenue Surges on Higher Ophthalmic Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099200","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099200?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:24","pubTimestamp":1787927067,"startTime":"0","endTime":"0","summary":"China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product salesOverviewChina ophthalmic pharma firm's half-year revenue rose 44.1% yr/yr to RMB423.7 mlnAdjusted net loss narrowed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0NI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1209","BK1587","BK1574","06622","01477","BK1583","02219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099255","title":"Ocumension Therapeutics Shifts Hk$102.5 Million IPO Proceeds to Working Capital, General Corporate Uses","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099255","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099255?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:21","pubTimestamp":1787926882,"startTime":"0","endTime":"0","summary":"Ocumension Therapeutics shifts HK$102.5 million IPO proceeds to working capital, general corporate usesOcumension shifted capital planning toward broader commercial operations, reallocating remaining ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL60mWRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099986","title":"Ocumension Therapeutics FY26 H1 Net Loss Narrows 25.2% to RMB 99.02 Million; Revenue Rises 44.1% to RMB 423.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099986","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099986?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:15","pubTimestamp":1787926549,"startTime":"0","endTime":"0","summary":"Ocumension Therapeutics FY26 H1 net loss narrows 25.2% to RMB 99.02 million; revenue rises 44.1% to RMB 423.7 millionOcumension Therapeutics revenue rose 44.1% to RMB 423.7 million for the six months ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLbKvvMw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662999470","title":"Ocumension Therapeutics - Board Does not Recommend Distribution of an Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2662999470","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662999470?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:15","pubTimestamp":1787926532,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P1VM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099671","title":"Ocumension Therapeutics - Adjusted Net Loss Narrowed by 46.7% to Rmb57.5 Mln for Six Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099671?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:15","pubTimestamp":1787926532,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P1VM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662096191","title":"Alphamab Oncology - Board Resolves to Repurchase Shares up to HK$80 Mln in Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662096191","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662096191?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:56","pubTimestamp":1787925376,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P1XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509616","title":"Alphamab Oncology Launches On-Market Share Buyback of up to HK$ 80 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509616","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662509616?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:55","pubTimestamp":1787925346,"startTime":"0","endTime":"0","summary":"Alphamab Oncology launches on-market share buyback of up to HK$ 80 millionAlphamab Oncology authorized an on-market share buyback of up to HK$80 million, starting Aug. 28, 2026.Repurchases will be fun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL21zqMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171474901","title":"EDDING GENOR Reports Interim Loss, Swinging to Deficit in First Half","url":"https://stock-news.laohu8.com/highlight/detail?id=1171474901","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171474901?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:50","pubTimestamp":1787925016,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) has announced its financial results for the six-month period ended June 30, 2026, revealing a notable shift from profitability to a net loss.During the reporting period, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662951720","title":"China's Zhaoke Ophthalmology H1 Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2662951720","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662951720?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:24","pubTimestamp":1787923484,"startTime":"0","endTime":"0","summary":"China's Zhaoke Ophthalmology H1 revenue risesOverviewChina ophthalmic drug maker's interim revenue rose yr/yr to RMB 18.8 mlnNon-HKFRS adjusted loss for the period widened slightly to RMB 116.1 mlnCom","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","03692","06622","BK1587","02616","BK1191","BK1209","BK1589","BK1574","02219","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662951250","title":"Suzhou Basecare FY26 H1 Net Loss Narrows 40.7% to RMB 72.05 Million; Revenue Rises 27% to RMB 128.75 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662951250","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662951250?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:23","pubTimestamp":1787923391,"startTime":"0","endTime":"0","summary":"Suzhou Basecare FY26 H1 net loss narrows 40.7% to RMB 72.05 million; revenue rises 27% to RMB 128.75 millionSuzhou Basecare posted revenue of RMB 128.75 million for the six months ended June 30, 2026,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9lJSRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","BK1574","02170","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662696095","title":"Zhaoke Ophthalmology FY26 H1 Loss Widens to RMB 122.59 Million; Revenue Rises 19.14% to RMB 18.83 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662696095","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662696095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:16","pubTimestamp":1787923002,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology FY26 H1 loss widens to RMB 122.59 million; revenue rises 19.14% to RMB 18.83 millionZhaoke Ophthalmology posted revenue of RMB 18.83 million, up 19.14% for the six months ended Ju","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL4x0NrM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06622","BK1587","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662409300","title":"Mabpharm FY26 H1 Profit More than Doubled to RMB 31.36 Million; Revenue Rises 45.1% to RMB 397.94 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662409300","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662409300?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:05","pubTimestamp":1787922358,"startTime":"0","endTime":"0","summary":"Mabpharm FY26 H1 profit more than doubled to RMB 31.36 million; revenue rises 45.1% to RMB 397.94 millionMabpharm posted a swing to profit, with attributable earnings of RMB 31.36 million, versus RMB ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLc92Mfg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02181","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098078","title":"Edding Genor Swings to FY26 H1 Net Loss of RMB 65.88 Million; Revenue Falls 23.1% to RMB 872.73 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098078","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098078?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:40","pubTimestamp":1787920807,"startTime":"0","endTime":"0","summary":"Edding Genor swings to FY26 H1 net loss of RMB 65.88 million; revenue falls 23.1% to RMB 872.73 millionEdding Genor posted a net loss of RMB 65.88 million, swinging from profit in the year-earlier per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL71J8MG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06998","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126390441","title":"Domestic Innovative Drug Sector Shifts From Cash Burn to Profit Generation as Mid-Year Reports Roll In","url":"https://stock-news.laohu8.com/highlight/detail?id=1126390441","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126390441?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920254,"startTime":"0","endTime":"0","summary":"As August draws to a close, the release of mid-year reports from innovative drug companies is accelerating, drawing heightened attention to the sector. How did domestic innovative drug developers...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","IBBQ","MEDX","BK1574","BK1161","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174722178","title":"ZyLoxTB Allocates HK$1.16M to Buy Back 53,000 Shares on August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1174722178","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174722178?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:28","pubTimestamp":1787920091,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced on August 28 that it spent HK$1.163 million to repurchase 53,000 shares of its own stock.According to the company's statement, the buyback transaction was executed on the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02190","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662933470","title":"CStone Pharmaceuticals (SEHK:2616) Stock Price Reflects Growth While Losses Stay Heavy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662933470","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662933470?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:26","pubTimestamp":1787919973,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals came into this print with its stock up 35.4% over the past month and another move to HK$5.89 into the close on 28 August. That price action reflects a growth story that investors already know is not yet profitable. The headline from these half year numbers is the size of the earnings hole. CStone reported a net loss of ¥252.3m for H1 2026 and trailing 12 month losses from continuing operations of ¥419.1m. The market is paying up for forecast growth while the income...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-stock-price-reflects-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/cstone-pharmaceuticals-sehk2616-stock-price-reflects-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060331","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return Reporting Share Repurchase at HKD 21.78-22.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060331","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060331?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:50","pubTimestamp":1787917803,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return reporting share repurchase at HKD 21.78-22.2Zylox-Tonbridge filed an HKEX next-day disclosure return showing a repurchase of 53,000 H shares on Au","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLrVW9h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1100","BK1587","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662935380","title":"Alphamab Oncology (SEHK:9966) Stock Rally Meets Revenue Dip And Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2662935380","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662935380?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:32","pubTimestamp":1787916728,"startTime":"0","endTime":"0","summary":"Alphamab Oncology stock has been on a short run higher, with the shares up about 15% over the past month. However, today’s earnings send a very different message. The headline is simple: revenue for the first half of 2026 came in at ¥271.2m, while the company reported a net loss of ¥40.5m and a basic loss per share of ¥0.04.\nFor a biotech that still trades on revenue potential more than profit, this contrast between top line and continuing losses is what the market is really reacting to. The...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-stock-rally-meets-revenue-dip-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-stock-rally-meets-revenue-dip-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09966","VGFPF","JOYT","VOTE","DECU","GXDW","FEBU","RGLO","BK1574","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163785274","title":"Goldman Sachs Lifts Innocare Price Target to HK$22.71 on Robust Orelabrutinib Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1163785274","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163785274?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:40","pubTimestamp":1787906422,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a research report raising its earnings per share forecasts for INNOCARE (09969) for the 2026 to 2028 period, from 0.15, 0.05, and 0.32 yuan to 0.16, 0.08, and 0.37 yuan,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU2471134879.HKD","GS","LU0868494617.USD","BK1161","BK4516","LU1144417596.USD","BK4552","BK4588","LU2237443382.USD","LU1868837136.USD","IE00B19Z3B42.SGD","LU1668664300.SGD","LU2896262040.SGD","LU0868494708.USD","EWH","LU1894683264.USD","LU1868836914.USD","IE0004086264.USD","IE0004091025.USD","LU1804176565.USD","GSX","LU2237443895.HKD","IE00BFXG1179.USD","LU2265009873.SGD","LU2471134952.CNY","LU2237443978.SGD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU0061475181.USD","LU1868836757.USD","BK4550","BK4127","LU0251142724.SGD","688428","LU2237443465.HKD","LU0251131958.USD","LU1868837300.USD","LU2471134523.USD","BK1574","LU0048573561.USD","LU2237438978.USD","LU2750360997.AUD","09969","BK0239","LU1791807156.HKD","LU0345770993.USD","IE0034235188.USD","LU2237443622.USD","IE0002270589.USD","LU0106831901.USD","LU0345770308.USD","BK4585","LU0742534661.SGD","LU0942090050.USD","LU2237443549.SGD","LU2750360641.GBP","BK4533","LU0210536198.USD","LU2471134796.USD","LU0096364046.USD","LU1894683348.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137057087","title":"AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium","url":"https://stock-news.laohu8.com/highlight/detail?id=1137057087","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137057087?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:21","pubTimestamp":1787905307,"startTime":"0","endTime":"0","summary":"As of the close of trading on August 28, the latest A-H share premium data has been released, offering a comprehensive snapshot of the valuation gap between dual-listed stocks. The rankings highlight...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1148","LU2242644610.SGD","LU1242518857.USD","LU0320764599.SGD","LU1244550577.SGD","03908","LU0880133367.SGD","LU2097828474.EUR","LU0456854461.SGD","00187","LU0149721374.USD","03130","HK0000252152.HKD","06821","82846","LU0708995583.HKD","BK1147","03678","BK1533","BK1554","LU0173614495.USD","LU1064131342.USD","00916","BK1183","BK1522","LU0149534421.HKD","00991","LU0164939612.USD","LU0886674414.USD","LU0043850808.USD","LU0791591158.USD","LU0165289439.USD","IE0034224299.USD","LU2045819591.USD","00981","06185","LU1808992512.USD","LU1366334578.USD","IE00B031J352.USD","LU0231483743.USD","LU0072913022.USD","01812","LU0307460666.USD","SG9999002828.SGD","LU0370786039.SGD","LU1048596156.SGD","03968","SG9999002463.SGD","LU0797268264.HKD","LU1328277881.USD","LU2097828631.EUR","BK1105","LU1023057109.AUD","LU2039709279.SGD","LU0516423091.SGD","LU0039217434.USD","LU2476274308.USD","LU0254981946.USD","BK1574","02475","LU0737861772.HKD","LU1224709979.USD","LU0229945570.USD","LU0266512473.USD","LU0543330483.HKD","LU0140636845.USD","LU0049853897.USD","LU1720050803.USD","BK1190","LU0348766576.USD","BK1610","LU0128522157.USD","03143","BK1141","LU1688375341.USD","03296","LU2476274720.SGD","LU0329678170.USD","LU0890818403.SGD","02727","IE00BZ08YS42.EUR","LU0918141887.USD","LU0228367735.SGD","BK1562","LU2778985437.USD","IE00B543WZ88.USD","159982","LU0449509016.USD","LU0588546209.SGD","LU0269904917.USD","BK1558","00042","LU2399975544.HKD","02846","BK1516","LU1770034418.SGD","LU0244354667.USD","LU0648948544.HKD","BK1149","02068","LU0469268626.HKD","LU0540923850.HKD","LU0531970944.HKD","SG9999001093.SGD","LU0607220059.USD","BK1507","LU0871576103.HKD","LU1255011170.USD","IE00BVYPNP33.GBP","LU0823426308.USD","LU0315179316.USD","BK1614","03188","IE00BMCWC346.EUR","LU1960683339.HKD","LU1046422090.SGD","03328","LU0210526637.USD","LU0348825331.USD","LU1282649141.HKD","LU0106252389.USD","BK1576","LU0348735423.USD","LU0106959298.USD","LU0979878070.USD","01349","LU0509642566.USD","LU1251922891.USD","BK1170","02338","LU0516422366.SGD","SG9999006597.SGD","LU1152091754.HKD","07233","HK0000252160.HKD","HK0000352291.HKD","LU1880383440.USD","LU0348805143.USD","LU1008478684.HKD","01108","02359","LU0589944569.HKD","BK1144","HK0000352382.USD","LU0828238088.HKD","HK0000500386.USD","03200","LU0431992006.USD","LU0329678337.USD","BK1193","LU0620787316.HKD","LU2097828714.EUR","LU1366334651.USD","BK1560","IE00BF5LJ272.USD","LU0737861699.HKD","BK1191","IE0008368742.USD","LU0029875118.USD","399300","BK1214","LU1244550494.USD","IE00BZ08YT58.USD","IE00B031HY20.USD","LU0345780521.USD","03986","IE00BVYPNQ40.USD","BK1501","LU1988902786.USD","LU1880383366.USD","LU1504937902.USD","BK1163","LU0164880469.USD","LU0320764755.SGD","BK1161","LU1794554557.SGD","00638","BK1521","LU1769817179.HKD","LU0449515922.USD","IE00BYV24P56.USD","HK0001040143.USD","LU1655091616.SGD","LU1675838814.USD","LU1719994722.HKD","LU0348814723.USD","LU0266512127.USD","BK1202","LU0862451753.SGD","BK1154","LU0067412154.USD","LU1961090484.USD","02899","00568","LU0640798160.USD","LU0061477393.USD","LU0048580855.USD","LU2097828805.USD","LU0228659784.USD","BK1249","BK1523","LU1152091168.USD","LU0501845795.SGD","SG9999004220.SGD","83188","LU0488056044.USD","01057","LU1481107354.HKD","LU0082770016.USD","BK1546","LU0082770016.SGD","LU1242518931.SGD","LU0417516738.SGD","BK1526","SG9999014674.SGD","LU0348827113.USD","IE0032431581.USD","LU0051755006.USD","LU0096374516.USD","LU0531971595.HKD","LU2226246903.HKD","BK1506","IE00BGHQDM52.EUR","03308","SG9999001226.SGD","LU0823040885.USD","LU0052750758.USD","BK1551","LU0348767384.USD","LU0828237510.HKD","LU0821914370.USD","LU2008162690.USD","LU1105468828.SGD","LU1807302812.USD","LU0456846285.SGD","BK1205","LU0672654166.SGD","LU0054450605.USD","LU1211504680.USD","LU1188198961.HKD","LU0345780281.USD","BK1505","LU1303224171.USD","LU0327786744.USD","EWH","LU0359202008.SGD","02691","BK1116","LU0516422952.EUR","LU0348788117.USD","01033","BK1592","01989","00553","LU2177674079.SGD","LU0314109678.HKD","SG9999011746.SGD","LU0828237940.HKD","LU0791590937.USD","LU1813983027.USD","LU0634319403.HKD","LU0593848301.USD","BK1223","IE00B3M56506.USD","HK0000320223.HKD","LU0359201885.HKD","00300","LU0211977185.USD","HK0000306701.USD","IE00B29SXG58.USD","LU0163747925.USD","IE0031814852.USD","BK1198","LU1282649067.USD","LU0823426480.USD","LU2294711473.HKD","LU0164865239.USD","IE00B0169L03.USD","LU1244550221.USD","LU2264538146.SGD","BK1530","LU0181495838.USD","LU2394011477.USD","BK1514","LU0543330566.HKD","LU1993786604.SGD","LU2097828557.USD","LU0417516902.SGD","HK0000320264.USD","BK1544","LU0384037296.USD","IE00B5MMRT66.SGD","BK1607","LU0326950275.SGD","BK1125","LU0287142896.SGD","BK1564","IE00BZ08YR35.GBP","LU1282648689.USD","BK1122","IE0008369823.USD","LU0463099449.HKD","LU1115378108.SGD","LU0561508036.HKD","LU2125910500.SGD","LU0348816934.USD","BK1583","02827","LU1769817096.USD","LU0918141705.HKD","LU1831875114.USD","LU1282649810.SGD","LU3063872942.SGD","BK1515","LU0455707207.USD","BK1171","LU0456827905.SGD","HK0000306685.HKD","BK1594","LU0572944931.SGD","83130","HK0001040168.HKD","LU0868486357.SGD","LU0214875030.USD","BK1209","LU0516422440.USD","03750","LU0117841782.USD","BK1231","LU0359201612.USD","00317","06869","LU0328353924.USD","LU0502904849.HKD","LU1226287529.USD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":13,"totalSize":260,"code":"91000000","status":"200"}]}}